Received Nov 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 4F9T5 | — |
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5DH4A | — |
Priorix and Rotarix vaccines that were administered to patient after the excursions; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received MMR (Priorix) (batch number 4F9T5, expiry date 01-MAR-2027) for prophylaxis. Co-suspect products included Rota (Rotarix liquid formulation) (batch number 5DH4A, expiry date 11-DEC-2026) for prophylaxis. On 14-NOV-2025, the patient received Priorix and Rotarix liquid formulation. On an unknown date, an unknown time after receiving Priorix and Rotarix liquid formulation, the patient experienced incorrect storage of drug (Verbatim: Priorix and Rotarix vaccines that were administered to patient after the excursions). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 17-NOV-2025 The Reporter had requested stability data for Menveo (1-vial), Kinrix, Boostrix, Infanrix, Engerix-B, Hiberix, Rotarix, and Priorix that had been stored at 11.1degree celcius for 1 hour and 15 minutes on Friday, 14-Nov-2025, following a power outage. There had been no prior excursions. Priorix and Rotarix were two known vaccines that had been administered to a patient after the excursions.